As of Jul 31
| +1.14 / +1.77%|
The 16 analysts offering 12-month price forecasts for Imperva Inc have a median target of 67.00, with a high estimate of 80.00 and a low estimate of 50.00. The median estimate represents a +1.98% increase from the last price of 65.70.
The current consensus among 18 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.